Isothermal Nucleic Acid Amplification Technology (INAAT) Market, by Product Type (Instruments and Reagents), by Technology (Helicase Dependent Amplification (HAD), Nicking Enzyme Amplification Reaction (NEAR), Nucleic Acid Sequence Based Amplification (NASBNA), Transcription medicated amplification (TMA), Single primer Isothermal Amplification (SPIA), and Loop-mediated Isothermal Amplification (LAMP)), by Application (Blood Screening, Oncology, Research and Development activities, and Others), by End User (Academic and Research Institutes, Diagnostic Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026
- Report code : CMI12831 |
- Industry :
Biotechnology
- Published On : Jul 2019 |
- Pages : 177 Pages |
- Format :
Global Isothermal Nucleic acid Amplification Technology (INAAT) Market Insights
Nucleic acid sequence-based amplification is a type of molecular biology, which is used to amplify RNA sequences. Isothermal Nucleic acid Amplification Technology (INAAT) is divided into several methods such as transcription mediated amplification, nucleic acid sequence-based amplification, signal mediated amplification of RNA technology, and others. Such many methods of isothermal nucleic acid amplification technology, in order to amplify the RNA sequences enable the market to grow at a meteoric growth during the forecast period.
The global isothermal nucleic acid amplification technology (INAAT) market was valued at US$ 1,724.0 million in 2018, and is expected to witness a CAGR of 13.6% during the forecast period (2019 – 2026).
Figure 1. Global Isothermal Nucleic acid Amplification Technology (INAAT) Market Share (%), by Product Type
Source: Coherent Market Insights Analysis (2019)
Collaboration strategies adopted by key players is expected to drive global isothermal nucleic acid amplification market growth
Increasing collaboration activities by key players is expected to boost global isothermal nucleic acid amplification technology (INAAT) market growth. For instance, in January 2017, Diagenode S.A. collaborated with Heidelberg University Hospital and the German Cancer Research Center (DKFZ). Under this collaboration Diagenode S.A focuses on development of high-sensitivity DNA amplification method. This method is for RNA sequencing library preparation solutions.
Moreover, key players in the market are focused on product launches for molecular diagnosis, which is expected to propel global isothermal nucleic acid amplification technology (INAAT) market growth. For instance, in April 2019, QuantaBio launched new freeze-dried lyophilized single-reaction reagent, Qscript lyo 1-step. Qscript lyo 1-step is a dry, stable, easy, and better 1-step RT-qPCR (quantitative reverse transcription polymerase chain reaction). It is highly sensitive and reproducible RT-qPCR. The reagent contains a thermo-stable polymerase.
Isothermal Nucleic acid Amplification Technology (INAAT) Market - Regional Analysis
North America isothermal nucleic acid amplification technology (INAAT) market is expected to account for the largest market share during the forecast period, owing to increasing product launch activities by key players. For instance, in September 2017, Bio-Rad Laboratories, Inc. launched RT-PCR (reverse transcriptase-polymerase chain reaction) kit in the U.S market. RT-PCR assay kit is a one-step procedure, where reverse transcription and gene amplification is performed in single tube. RT-PCR assay kit is used for DNA identification and amplification.
Furthermore, Asia pacific is expected to gain significant share in the global isothermal nucleic acid amplification technology (INAAT) market over the forecast period, owing to increasing launches of new products in this region. For instance, in July 2015, Takara Bio Inc., a Japanese company, launched real-time PCR system Thermal Cycler Dice Real Time System III. This system is used for rapid gene amplification. RT- PCR (reverse transcriptase-polymerase chain reaction) is used in various fields including food inspection, clinical examination, and personal genetic analysis.
Moreover, Europe is also projected to witness significant growth in the global isothermal nucleic acid amplification technology (INAAT) market, owing to increasing approval activities by regulatory authorities. For instance, in September 2017, Tetracore Inc. received an approval from European Economic Area (EEA) for its T-COR 8, which is a portable real-time PCR thermocycler. T-COR 8 is a molecular diagnostic platform used for detection and identification of infectious agents as well as nucleic acid amplification.
Figure 2: Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Value (US$ Mn), By Region
Source: Coherent Market Insights Analysis (2019)
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market - Competitive Landscape
Key players operating in the isothermal nucleic acid amplification technology (INAAT) market include Alere Inc., Becton, Dickinson & Company, BioHelix Corporation, BioMerieux Biotechnology Company, Hologic Gene-Probe, QIAGEN Company, Thermo Fisher Scientific, Inc., Lucigen Corporation, Quidel Corporation, and NuGEN.
Isothermal nucleic acid technologies are used in recombinant DNA and molecular biology techniques. These techniques are used in detection and analysis of a small quantity of nucleic acids. Polymerases chain reaction is based on isothermal nucleic acid amplification technology. The polymerase chain reaction (PCR) is most widely used method for DNA amplification. Polymerase chain reaction (PCR) is used for the detection and identification of infectious diseases, genetic disorders, and for research purposes. PCR consists a thermocycling machine, which facilitates separation and amplification of DNA strands.
Market Dynamics
Increasing approvals from healthcare regulatory authorities for innovative technologies is expected to drive the global isothermal nucleic acid amplification technology (INAAT) market growth. For instance, in October 2018, Abbott laboratories received the U.S. Food and Drug Administration (FDA) for its next-generation Influenza A & B2 and Strep A2 molecular assays. These assays are used for the molecular detection and differentiation of influenza A and B virus. Next-generation Influenza A & B2 and Strep A2 molecular assays are currently available on ID NOW platform, which is a rapid isothermal system. It is used for the detection of infectious diseases such as influenza.
Furthermore, rising product launches by key players is expected to boost the global isothermal nucleic acid amplification technology (INAAT) market growth. For instance, in July 2017, TwistDx Inc. launched TwistAmp, a recombinase polymerase amplification (RPA) kit. It is used for DNA/RNA amplification. TwistAmp is an isothermal alternative to polymerase chain reaction PCR.
Key features of the study:
- This report provides in-depth analysis of the global isothermal nucleic acid amplification technology (INAAT) market size (US$ Mn), and compound annual growth rate (CAGR %) for the forecast period (2018–2026), considering 2017, as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global isothermal nucleic acid amplification technology (INAAT) market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include, Alere Inc., Becton, Dickinson & Company, BioHelix Corporation, BioMerieux Biotechnology Company, Hologic Gene-Probe, QIAGEN Company, Thermo Fisher Scientific, Inc., Lucigen Corporation, Quidel Corporation, and NuGEN
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global isothermal nucleic acid amplification technology (INAAT) market report caters to various stakeholders in this industry including investors, product manufacturers, distributors, and suppliers for isothermal nucleic acid amplification technology (INAAT) market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
- Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Product Type:
- Instruments
- Reagents
- Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Application:
- Blood Screening
- Oncology
- Research and Development Activities
- Others
- Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Technology:
- Helicase Dependent Amplification (HAD)
- Nicking Enzyme Amplification Reaction (NEAR)
- Nucleic Acid Sequence Based Amplification (NASBA)
- Transcription Medicated Amplification (TMA)
- Single Primer Isothermal Amplification (SPIA)
- Loop-mediated Isothermal Amplification (LAMP)
- Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By End User Type:
- Academic and Research Institutes
- Diagnostic Laboratories
- Others
- Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market , By Region:
- North America
- By Country:
- U.S.
- Canada
- By Product Type:
- Instruments
- Reagents
- By Technology:
- Helicase Dependent Amplification (HAD)
- Nicking Enzyme Amplification Reaction (NEAR)
- Nucleic Acid Sequence Based Amplification (NASBA)
- Transcription Medicated Amplification (TMA)
- Single Primer Isothermal Amplification (SPIA)
- Loop-mediated Isothermal Amplification (LAMP)
- By Application:
- Blood Screening
- Oncology
- Research and Development Activities
- Others
- By End User Type:
- Academic and Research Institutes
- Diagnostic Laboratories
- Others
- By Country:
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Product Type:
- Instruments
- Reagents
- By Technology:
- Helicase Dependent Amplification (HAD)
- Nicking Enzyme Amplification Reaction (NEAR)
- Nucleic Acid Sequence Based Amplification (NASBA)
- Transcription Medicated Amplification (TMA)
- Single Primer Isothermal Amplification (SPIA)
- Loop-mediated Isothermal Amplification (LAMP)
- By Application:
- Blood Screening
- Oncology
- Research and Development Activities
- Others
- By End User Type:
- Academic and Research Institutes
- Diagnostic Laboratories
- Others
- By Country:
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Product Type:
- Instruments
- Reagents
- By Technology
- Helicase Dependent Amplification (HAD)
- Nicking Enzyme Amplification Reaction (NEAR)
- Nucleic Acid Sequence Based Amplification (NASBA)
- Transcription Medicated Amplification (TMA)
- Single Primer Isothermal Amplification (SPIA)
- Loop-mediated Isothermal Amplification (LAMP)
- By Application:
- Blood Screening
- Oncology
- Research and Development Activities
- Others
- By End User Type:
- Academic and Research Institutes
- Diagnostic Laboratories
- Others
- By Country:
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Product Type:
- Instruments
- Reagents
- By Technology:
- Helicase Dependent Amplification (HAD)
- Nicking Enzyme Amplification Reaction (NEAR)
- Nucleic Acid Sequence Based Amplification (NASBA)
- Transcription Medicated Amplification (TMA)
- Single Primer Isothermal Amplification (SPIA)
- Loop-mediated Isothermal Amplification (LAMP)
- By Application:
- Blood Screening
- Oncology
- Research and Development Activities
- Others
- By End User Type:
- Academic and Research Institutes
- Diagnostic Laboratories
- Others
- By Country:
- Middle East
- By Country:
- GCC Countries
- Israel
- Rest of Middle East
- By Product Type:
- Instruments
- Reagents
- By Technology:
- Helicase Dependent Amplification (HAD)
- Nicking Enzyme Amplification Reaction (NEAR)
- Nucleic Acid Sequence Based Amplification (NASBA)
- Transcription Medicated Amplification (TMA)
- Single Primer Isothermal Amplification (SPIA)
- Loop-mediated Isothermal Amplification (LAMP)
- By Application:
- Blood Screening
- Oncology
- Research and Development Activities
- Others
- By End User Type:
- Academic and Research Institutes
- Diagnostic Laboratories
- Others
- By Country:
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Product Type:
- Instruments
- Reagents
- By Technology:
- Helicase Dependent Amplification (HAD)
- Nicking Enzyme Amplification Reaction (NEAR)
- Nucleic Acid Sequence Based Amplification (NASBA)
- Transcription Medicated Amplification (TMA)
- Single Primer Isothermal Amplification (SPIA)
- Loop-mediated Isothermal Amplification (LAMP)
- By Application:
- Blood Screening
- Oncology
- Research and Development Activities
- Others
- By End User Type:
- Academic and Research Institutes
- Diagnostic Laboratories
- Others
- By Country/Region:
- North America
- Company Profiles
- Alere Inc.,*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Becton, Dickinson & Company
- BioHelix Corporation
- BioMerieux Biotechnology Company
- Hologic Gene-Probe
- QIAGEN Company
- Thermo Fisher Scientific, Inc.
- Lucigen Corporation
- Quidel Corporation
- NuGEN
- Alere Inc.,*
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Technology Advancements
- Historical Overview
- Merger and Acquisition
- Regulatory Scenario
- PORTER’S Five Forces
- PEST Analysis
- Market Dynamics
- Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Product Type, 2018 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Application, 2018 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Helicase Dependent Amplification (HAD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Nicking Enzyme Amplification Reaction (NEAR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Nucleic Acid Sequence Based Amplification (NASBA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Transcription Medicated Amplification (TMA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Single Primer Isothermal Amplification (SPIA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Loop-mediated Isothermal Amplification (LAMP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Application, 2018 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Blood Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Research and Development Activities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market By End User, 2018 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global, Isothermal Nucleic Acid Amplification Technology (INAAT) Market By Region, 2018 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, By Region, 2017 – 2026
- Regional Trends
- North America
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Technology, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application , 2016 – 2026, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Technology , 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Technology, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By End User 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- Japan
- China
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Technology, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Million
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Technology, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Million
- Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Technology, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Alere, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Becton, Dickinson & Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- BioHelix Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- BioMerieux Biotechnology Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Hologic Gene-Probe
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- QIAGEN Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Thermo Fisher Scientific
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Lucigen Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Quidel Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- NuGEN
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Alere, Inc.
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 33 market data tables and 31 figures on “Isothermal Nucleic Acid Amplification Technology (INAAT) Market” - Global forecast to 2026”.
Related Insights :
Share
Choose License Type
"How Can I Help You" ?
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Key Benefits
Custom Research Solution
Talk to our research consultant to design an exclusive report as per your research needs.
Customer Fulfilment
We aim to fulfil client's research demands with tailored research solutions.
Quick Turnaround Time Reports
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
360-degree Approach
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
Assured Quality
We strive to provide most accurate and reliable research findings in our research reports.